The DOJ Shows Its Sweet Tooth in Bid to Block Sugar Merger

The DOJ Shows Its Sweet Tooth in Bid to Block Sugar Merger

1 Dec 2021

As Americans settle into the holiday season, the Department of Justice has filed suit to protect consumers from potential price increases on a holiday cookie necessity: sugar. The DOJ aims to stop the sale of the Imperial Sugar Company (“Imperial”) from the Louis Dreyfus Company to Imperial’s competitor, the United States Sugar Corporation (“U.S. Sugar”). The refined sugar market, it claims, is already highly concentrated: U.S. Sugar is, itself, part of a “marketing cooperative,” United Sugars Corporation (“United”), with three other refined sugar producers (American Crystal Sugar Company, Minn-Dak Farmers Cooperative, and Wyoming Sugar Company, LLC). The United members do not compete with one another. 

The proposed merger of Imperial with U.S. Sugar would be, the DOJ alleges, particularly detrimental to the Southeast United States, where United and Imperial are two of the three largest suppliers of refined sugar. Together with the third largest—American Sugar Refining (better known as “Domino”)—they control approximately 75% of the market. This merger would, the DOJ alleges, eliminate the aggressive head-to-head competition that currently exists between United and Imperial and further concentrate an already-concentrated market, in violation of Section 7 of the Clayton Act. 

The merger would also, the DOJ claims, increase the incentive and ability for United and Domino to coordinate to raise prices, reduce output, or reduce the quality of sugar. This danger is not merely theoretical. The DOJ alleges, among other things, that soon after the deal was announced, a Domino vice president spoke directly with Imperial’s CEO and reported back to his Domino colleagues that U.S. Sugar’s acquisition of Imperial was “likely [] a good thing for us” and that “it’s going to be more important than ever to stay close to United.”  

In a press release, the DOJ said that U.S. Sugar’s acquisition of Imperial would “substantially lessen[] competition at a time when global supply chain challenges already threaten steady access to important commodities and goods. The department’s lawsuit seeks to preserve the important competition between U.S. Sugar and Imperial Sugar and protect the resiliency of American domestic sugar supply.”

The case is U.S. v. United States Sugar Corp., No. 21-cv-01644 (D. Del.).

Share this post on
About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in Atlanta, Los Angeles and Philadelphia.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About Raymond N. Barto

Raymond N. Barto’s practice is focused on antitrust litigation.  Ray is a Partner in the firm’s New York office.

Raymond N. Barto
Partner at Faruqi & Faruqi, LLP
New York office
Tel:(212) 983-9330
Fax:(212) 983-9331
E-mail:rbarto@faruqilaw.com
Tags: Antitrust, Clayton Act, DOJ, Domino, faruqi & faruqi, Faruqi and Faruqi, FaruqiLaw, Imperial Sugar Company, Louis Dreyfus Company, Raymond Barto, United Sugars Corporation

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771